scispace - formally typeset
Search or ask a question

How do neurodegenerative diseases impact cognitive function and daily living? 


Best insight from top research papers

Neurodegenerative diseases significantly impact cognitive function and daily living. These diseases lead to memory disorders, cognitive impairments, and a progressive loss of neuronal cells, resulting in dementia . Cognitive functions affected include memory, attention, language, and thinking, necessitating a detailed neuropsychological profile for accurate diagnosis and management . Studies have shown correlations between digital biomarkers, reflecting everyday function and cognition, with neuropathological markers in aging cohorts, indicating the potential for these markers to serve as behavioral proxies for neurodegenerative processes . Early detection through techniques like MRI and deep learning approaches is crucial for efficient care and differential diagnosis of various types of dementia, such as Alzheimer’s disease, Frontotemporal dementia, Parkinson’s disease, and dementia with Lewy bodies .

Answers from top 5 papers

More filters
Papers (5)Insight
Neurodegenerative diseases, like Alzheimer's, can impact cognitive function and daily living, as shown by correlations between digital biomarkers and neuropathological markers in aging cohorts.
Neurodegenerative diseases like multiple sclerosis can lead to cognitive deficits affecting memory, attention, and work ability, impacting daily living and necessitating timely detection for improved patient quality of life.
Neurodegenerative diseases like multiple sclerosis can lead to cognitive deficits affecting memory, attention, and daily functioning, emphasizing the importance of timely detection for improved quality of life.
Neurodegenerative diseases like Alzheimer's, Frontotemporal dementia, Parkinson's, and Lewy body dementia lead to memory and cognitive impairments, affecting daily function, emphasizing the need for early detection and differential diagnosis.
Open accessBook ChapterDOI
01 Jan 2023
Neurodegenerative diseases lead to neuronal loss, affecting cognitive function and daily living. Glial dysfunction plays a crucial role, and lifestyle changes can enhance neuroprotection, potentially delaying neurodegeneration.

Related Questions

What are the beginnings for a person with a neurodegenerative disease?5 answersThe onset of neurodegenerative diseases (NDDs) typically involves a gradual decline in immunological resistance due to various stressors, leading to tissue vulnerability and subsequent viral attacks, as suggested by Pierpaoli. This attack triggers the production of autoantigens and autoantibodies, perpetuating a vicious cycle that contributes to the emergence of NDDs. Symptoms of NDDs often manifest after significant neuronal death and the depletion of brain compensatory mechanisms, highlighting the critical importance of early detection and intervention. In the case of Huntington's disease, initial symptoms may include mild motor impairments like clumsiness and slowed gait, progressing to more severe manifestations such as dystonia, chorea, and cognitive decline over time. Understanding these early signs and underlying mechanisms is crucial for developing effective diagnostic tools and treatments for individuals at risk of or affected by NDDs.
How many people suffer from neurodegenerative disorders in the world?5 answersApproximately 50 million people worldwide suffer from neurodegenerative diseases, with Alzheimer's Disease (AD) and Parkinson's Disease (PD) being the most common types, affecting around 15% of the global population. The prevalence of these disorders is expected to increase significantly due to aging populations, with projections estimating that the number of individuals affected by AD alone will nearly double by 2025, reaching around 34 million. Moreover, the number of people diagnosed with AD is predicted to escalate to 115 million by 2050, highlighting the growing burden of neurodegenerative disorders on public health globally. These statistics underscore the urgent need for more effective treatments with fewer side effects to address the rising prevalence of neurodegenerative diseases.
What are the mechanisms behind neurodegenerative diseases?5 answersNeurodegenerative diseases are characterized by the progressive loss of cognitive and/or motor function. Recent genetic and mechanistic studies have revealed common cellular pathways involved in these diseases, including defective protein quality-control and degradation pathways, dysfunctional mitochondrial homeostasis, stress granules, and maladaptive innate immune responses. Inflammatory cytokines and tryptophan metabolites called kynurenines have been found to play a role in neurodegenerative diseases, with increases in pro-inflammatory cytokines and neurotoxic kynurenines observed in these conditions. Multiple sclerosis, a major cause of neurological disability, involves immune reactions, oxidative and nitrosative stress, mitochondrial damage, and impaired energy production, leading to progressive proteolytic degradation of cytoskeleton proteins and loss of axonal energy. The complexity of neurodegenerative diseases has made it challenging to unravel their mechanisms, but bioinformatics and modeling approaches have been developed to identify candidate mechanisms based on publicly available data and knowledge. Parkinson's disease and other parkinsonian syndromes involve the progressive dysfunction of specific populations of neurons, with neuronal loss and accumulation of misfolded proteins playing a role in their pathogenesis.
What is the connection between emotions, cognition and neurodegenerative diseases?4 answersEmotions, cognition, and neurodegenerative diseases are interconnected. Neurodegenerative diseases, such as Parkinson's disease (PD), Alzheimer's disease (AD), and behavioral variant frontotemporal dementia (bvFTD), can lead to disruptions in emotional, cognitive, and social behavior. PD is characterized by motor symptoms, but it also involves non-motor symptoms like cognitive dysfunctions and emotional disturbances. Caregiving for individuals with neurodegenerative diseases is associated with increased rates of depression and anxiety. Neurodegenerative diseases can lead to severe physical and psychological disabilities, including cognitive impairment, dementia, and depression. Research has shown that patients with bvFTD and AD exhibit impairments in moral emotions, which are associated with specific brain regions. Neurodegenerative diseases provide a model system for studying the neural correlates of emotional and behavioral symptoms, offering insights into the assessment, prevention, and treatment of mental illness.
What are neurodegenerative diseases?5 answersNeurodegenerative diseases (NDs) are a heterogeneous group of complex diseases characterized by neuronal loss and progressive degeneration of different areas of the nervous system. These diseases are associated with gene mutations leading to protein dysfunction. The exact pathogenesis of NDs is still unclear, but it is believed to involve a complex interaction among genetic, epigenetic, and environmental factors. Neuroglia, including glial cells, play a fundamental role in the pathophysiology of neurodegenerative diseases. NDs can result in dementia and are a major cause of death worldwide. Currently, there are no effective therapeutics to slow, halt, or prevent NDs. However, research is ongoing to understand the molecular mechanisms underlying the pathogenesis of NDs and to develop new drugs for their treatment.
What is the link between mental health and neurodegenerative disease?2 answersMental health, specifically major depressive disorder (MDD), has been found to have a strong relationship with neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Amyotrophic Lateral Sclerosis (ALS), and natural aging processes. The pathophysiology of these mental health disorders involves neurodegenerative processes, dysfunctions in neurotransmitter systems, and developmental abnormalities. Additionally, there is evidence of a connection between AD and PD with other chronic diseases such as cancer, diabetes, and cardiovascular diseases, suggesting common molecular mechanisms. Furthermore, there are commonalities in the mechanisms operating in both neurodevelopmental and neurodegenerative diseases, indicating a link between mental health and neurodegenerative diseases. Neuroinflammation has been identified as a major contributing factor to both neurodegeneration and depression, with dysregulation of pro- and anti-inflammatory cytokines playing a role. Overall, these findings highlight the complex relationship between mental health and neurodegenerative diseases, suggesting shared mechanisms and potential points of intervention.

See what other people are reading

What is the definition of autism spectrum disorder?
5 answers
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication, restricted repetitive behaviors, and atypical prosody in speech patterns. Initially considered a symptom of schizophrenia, ASD is now recognized as a distinct condition impacting social interactions and communication. ASD manifests prenatally with morphological brain abnormalities and affects various aspects of an individual's life, including social, language, and play development, wellness, and transitions into adolescence and adulthood. The disorder's complexity involves genetic, biochemical, and cellular factors, necessitating a multidimensional approach to management. Treatment strategies encompass behavioral therapy and pharmacological interventions targeting co-occurring conditions like anxiety, depression, aggression, inattention, and sleep disorders.
How do emotional control and positive thinking affect the well-being of psychiatric patients' caregivers?
5 answers
Emotional control and positive thinking significantly impact the well-being of psychiatric patients' caregivers. Caregivers facing challenges in providing care for family members with schizophrenia often lack efficient support systems and struggle with emotional expression, highlighting the importance of emotional control. Positive mental health (PMH) plays a crucial role in caregivers' well-being, with higher levels of PMH associated with better coping skills and overall emotional well-being. In the context of behavioral-variant frontotemporal dementia (bvFTD), disrupted positive emotional connections between caregivers and patients contribute to lower emotional well-being, emphasizing the significance of emotional bonds in caregiver support. Additionally, caregiver burden is negatively correlated with quality of life, indicating that managing emotional stress and maintaining positive thinking are vital for caregivers' overall well-being.
How does the mechanism of cell competition contribute to the aging process in basal keratinocytes?
5 answers
The mechanism of cell competition contributes to the aging process in basal keratinocytes through fluctuations in the expression of specific proteins like collagen XVII (COL17A1). This fluctuation, induced by genomic/oxidative stress, leads to differential expression levels of COL17A1 among individual stem cells, creating a driving force for cell competition. Clones expressing high levels of COL17A1 outcompete and eliminate adjacent stressed clones with low COL17A1 expression, ultimately affecting tissue homeostasis and aging. The loss of COL17A1 in high-potential stem cells limits their competitive ability, contributing to skin aging by causing hemidesmosome fragility and stem cell delamination, depleting neighboring cells and promoting skin aging. This process highlights potential therapeutic targets for anti-aging interventions in basal keratinocytes.
What is the role of cellular prion protein in PIP metabolism?
4 answers
The cellular prion protein (PrPC) plays a crucial role in lipid metabolism and energetic regulation. PrPC contributes to the regulation of energetic metabolism by promoting mitochondrial oxidative degradation of glucose, limiting fatty acid oxidation, and preventing oxidative stress. Additionally, PrPC is involved in optimizing glutamate secretion, regulating Ca2+ entry, and protecting neurons from excitotoxicity. PrPC is also implicated in controlling Ca2+ homeostasis, potentially through the modulation of signaling pathways like p59Fyn- and p42/p44-ERK-dependent pathways. The multifaceted functions of PrPC, including its involvement in lipid metabolism, energetic regulation, and Ca2+ homeostasis, highlight its significance in cellular processes and neuroprotection.
How accurate and reliable are genetic methylation tests for diagnosing and predicting diseases?
5 answers
Genetic methylation tests show high accuracy and reliability in diagnosing and predicting diseases. Studies demonstrate that DNA methylation-based predictors exhibit excellent test-retest reliability when appropriate data processing strategies are employed. For instance, a diagnostic panel of five CpG markers achieved a correct rate of 100% in distinguishing cervical cancer from normal tissues, with high sensitivity and specificity. Additionally, a precision DNA methylation test, CervicalMethDx, accurately classified samples with cervical intraepithelial neoplasia grades 2 and 3, showing 93-100% sensitivity and specificity. Moreover, age prediction models using DNA methylation biomarkers have shown promising results for both healthy and diseased samples, with Random Forest Regression performing the best. These findings highlight the potential of genetic methylation tests in disease diagnosis and prognosis prediction.
What is the role of gut microbiome in ALS?
5 answers
The gut microbiome plays a significant role in Amyotrophic Lateral Sclerosis (ALS) by influencing disease development and progression through the brain-gut-microbiota axis. Studies have shown that alterations in gut microbial communities, such as an increase in Escherichia coli, can exacerbate ALS symptoms and pathology. Dysregulation of the gut microbiota can lead to changes in brain-gut signaling, affecting the intestinal barrier, endotoxemia, and systemic inflammation, all contributing to ALS progression. Chronic exposure to specific gut bacteria can induce shifts in immune responses, inflammation, and organ pathology, impacting ALS outcomes. Understanding the gut microbiome's involvement in ALS is crucial for developing effective diagnostic and therapeutic strategies to manage this devastating neurodegenerative disease.
What are some novel treatments currently being explored for ALS?
5 answers
Several novel treatments are being explored for ALS. These include an oral tyrosine kinase inhibitor, RIPK1 inhibition, mesenchymal stem cells, antisense oligonucleotides, sequential administration of experimental treatments, and modification of the patient's own mesenchymal stem cells. Additionally, there are 53 new drugs evaluated in clinical trials, classified into eight mechanistic groups, with promising candidates like methylcobalamin, masitinib, AMX0035, CNM-Au8, and tofersen showing potent therapeutic effects. Clinical investigational small molecules and biological-based therapies are also under development, with a focus on proteostasis mechanisms to potentially modify ALS progression. Despite the challenges in finding a suitable therapy, breakthroughs in targeting genetic disease forms offer hope for improved care and therapy for ALS patients.
How does music therapy impact the neurological and psychological symptoms of neurodegenerative disorders?
5 answers
Music therapy has shown promising effects on neurological and psychological symptoms of neurodegenerative disorders like Alzheimer's and Parkinson's diseases. Music therapy enhances comfort and can improve speech, memory, and behavior. It affects patients through cognitive channels, altered brain structures, and neural systems, potentially targeting mechanisms involved in the pathogenesis of these diseases. Music intervention influences physiological systems positively, impacting pain modulation, exercise performance, cardiac functions, emotions, stress, and biological rhythms. Additionally, neurologic music therapy has been explored as a non-pharmacological intervention for managing behavioral and psychological symptoms in dementia patients, showing improvements in neuropsychiatric symptoms. Studies have demonstrated the beneficial effects of music therapy in reducing psychological and behavioral symptoms in Alzheimer's patients.
WHO 2021 Adult-type diffuse gliomas identification test?
4 answers
The identification test for adult-type diffuse gliomas according to the WHO 2021 classification involves utilizing 18 F-fluoromisonidazole (FMISO) PET imaging in combination with apparent diffusion coefficient (ADC) measurements. This test aims to differentiate between mutant-type isocitrate dehydrogenase (IDH-mutant) and wild-type IDH (IDH-wildtype) gliomas. Studies have shown that the relative SUV mean in hyperintense areas and contrast-enhanced tumors, along with ADC values, can effectively distinguish between IDH-mutant and IDH-wildtype gliomas. Additionally, the integration of molecular alterations such as chromosome alterations, CDKN2A/B, PIK3CA, and PTEN, as well as KMT5B and MET, can further aid in the identification and characterization of adult patients with pediatric-type diffuse gliomas.
What are principles of palliative care?
5 answers
The principles of palliative care encompass a multidisciplinary approach to improving the quality of life for patients with life-limiting illnesses. These principles include effective communication between patients and clinicians, holistic symptom management, family support, and grief assistance. Palliative care emphasizes pain and symptom management, quality of life enhancement, and spiritual and emotional support for patients and their families. It involves providing care across various healthcare settings, such as hospitals, homes, hospices, and long-term care institutions, with a focus on addressing the physical, emotional, and spiritual needs of patients. Additionally, palliative care principles stress the importance of early rehabilitation interventions to maintain and improve patients' functional capacity and quality of life.
Who are the authors of the articles published in Volume 43, Issue 4 of the journal?
5 answers
The authors of the articles published in Volume 43, Issue 4 of the journal are not explicitly mentioned in the available abstracts. The abstracts from the provided contexts do not provide specific details regarding the authors of the articles in this particular issue. However, the contexts do offer information related to the publication dates, issue numbers, and access to the content. The available data does not directly address the authors of the articles in Volume 43, Issue 4 of the journal.